Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00651079 · ClinicalTrials.gov registry record · Phase 1
GSK1247303 First Time in Human Study
A Phase 1 study, sponsored by GlaxoSmithKline.
- Terminated
- Registry status
- Phase 1
- Development phase
- 58
- Enrollment target
NCT00651079 is a Phase 1 study that was terminated before completion, run by GlaxoSmithKline. The registered enrollment target is 58 participants.
The verdict
NCT00651079, a Phase 1 study, was terminated before completion, sponsored by GlaxoSmithKline.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 58 participants
- Enrollment target
Study Summary
To determine safety, tolerability and Pharmacokinetics of GSK1247303
Interventions
- DRUG GSK1247303
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2008-02 |
| Est. Completion | 2008-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00651079
The ClinicalTrials.gov registry entry for NCT00651079 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 58 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is GlaxoSmithKline, which has 1,345 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which GSK1247303 is the first listed.
NCT00651079 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00651079 about?
NCT00651079 is a clinical study titled "GSK1247303 First Time in Human Study". To determine safety, tolerability and Pharmacokinetics of GSK1247303
What is the current status of trial NCT00651079?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 58 participants. The study started on 2008-02. Estimated completion is 2008-05.
What interventions are being tested in trial NCT00651079?
The interventions under investigation include: GSK1247303 (DRUG).
Who is sponsoring clinical trial NCT00651079?
This trial is sponsored by GlaxoSmithKline, which has 1,345 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.